SCHEMBL20325225

SCHEMBL20325225

Nc1nc2c(ccn2[C@@H]2OC(COP(=O)(O)O)CC2OP(=O)(O)OCC2CC[C@H](n3cnc4c(N)ncnc43)O2)c(=O)[nH]1

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RNASEL Q05823 6/20 0.47
▸ STING1 Q86WV6 2/20 0.47
▸ DTYMK P23919 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20325237 0.87 RNASEL (0.48) RNASEL
SCHEMBL20327591 0.86 FUT5 (0.47) RNASELSTING1
SCHEMBL21539917 0.85 ALDH1A1 (0.51) RNASELSTING1DTYMK
SCHEMBL21540016 0.85 ALDH1A1 (0.51) RNASELSTING1DTYMK
SCHEMBL20782764 0.85 TERT (0.53) RNASEL
SCHEMBL21540009 0.85 TERT (0.53) RNASEL
SCHEMBL20324868 0.85 TERT (0.53) RNASEL
SCHEMBL20325223 0.85 TERT (0.53) RNASEL
SCHEMBL20325230 0.84 STING1 (0.46) RNASELSTING1DTYMK
SCHEMBL20325238 0.84 RNASEL (0.47) RNASEL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018118664-A1 COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT MERCK SHARP & DOHME CORP. (US) 2018-06-28 — — WO disclosed
Send feedback